After her cancer misdiagnosis, Lucy Liu advocates for early screening [USA TODAY]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: USA TODAY
She scheduled a procedure to remove the lump that same week. But when her breast cancer scare turned out to be a misdiagnosis , her perception of healthcare flipped inside out. “There was not a lot of research done behind it,” she tells USA TODAY, reflecting on the experience decades later. “There was not a lot of asking around. Now, I would ask a million questions and I would not be embarrassed about it.” Cancer is the second leading cause of death in the United States, exceeded only by heart disease, per the Center for Disease Control and Prevention (CDC), but early detection by mammography screening has contributed to a decline in breast cancer death rates, according to 2025-2026 data from American Cancer Society After discovering her surgery had been unnecessary, Liu says she learned about routine screening and diagnostic tools – ultrasounds, biopsies, mammograms. “That's when I really found out how much I didn't know and how I jumped the gun,” she says. The breast can
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.MarketBeat
- U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility [Yahoo! Finance]Yahoo! Finance
- U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility [TheStreet.com]TheStreet.com
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 4
- 4/10/26 - Form 3
- PFE's page on the SEC website